TDC
VIVE

Thompson Davis & Co’s VIVEVE MED INC VIVE Stock Holding History

Thompson Davis & Co’s Portfolio VIVE Stock Details VIVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Hold
0
– -$1K – 1143
2017
Q3 		– Sell
-1
Closed -$6.17K – 1093
2017
Q2 		$7K Buy
+1
New +$7.45K 0.01% 772

Other funds holding VIVE

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
IG
ING Group Amsterdam, Netherlands $16.4B AUM 34.6% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return

Thompson Davis & Co's VIVE Position: Q4 2017 in Review

Thompson Davis & Co held its VIVEVE MED INC (VIVE) position steady in Q4 2017 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1143.

Thompson Davis & Co first reported a position in VIVE in Q2 2017 and has held it in 1 quarter since. The position peaked at $7K in Q2 2017. 44 funds tracked by Wall St. Rank hold VIVE as of Q4 2017.

  • Thompson Davis & Co held 0 shares of VIVEVE MED INC worth $0 as of Q4 2017.
  • Thompson Davis & Co left its VIVEVE MED INC share count unchanged in Q4 2017.
  • VIVEVE MED INC made up ﹤0.01% of Thompson Davis & Co's portfolio in Q4 2017, its #1143 holding.
  • Thompson Davis & Co first reported a position in VIVEVE MED INC in Q2 2017 and has held it in 1 quarter since.
  • Thompson Davis & Co's VIVEVE MED INC position peaked at $7K in Q2 2017.
  • 44 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q4 2017.

Based on Thompson Davis & Co's 13F filing for Q4 2017, filed 5 Feb 2018.